Amyris Launches Next Virtual Investor Mini-Series
EMERYVILLE, Calif., Aug. 16, 2021 /PRNewswire/ -- Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be hosting an encore to its first three-part virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology". The first three webinars in Amyris' investor series focused on the power of Amyris' proprietary Lab-to-MarketTM biotechnology platform, its clean beauty consumer brands, and its ingredients pipeline. The goal is to continue to engage and educate current and prospective investors about Amyris' busines model and the power of its platform. Amyris will host its fourth webinar titled Lab-to-Market, Delivering Disruptive Health and Beauty Products on Tuesday September 28, 2021 at 1:00pm ET (10:00 am PT). The session will include a presentation regarding Amyris' differentiated cannabigerol ("CBG") ingredient and its product formulation that clears the skin and reduces bone inflammation and other body pains for topical application, followed by a live Q&A. Webcast details will be published closer to the date of the webinar. Amyris plans to hold a fifth and sixth session in the series focused on its advantaged portfolio before the end of 2021. "We have received very positive feedback on our virtual investor mini-series and have decided to continue with this successful format to inform and educate our stakeholders," commented John Melo, President and Chief Executive Officer. "We are executing very well on our Lab-to-Market capability to create, manufacture and sell differentiated ingredients and disruptive consumer products which are at the core of our winning business model. We are experiencing strong demand for our ingredients and are accelerating growth with our consumer brands in the third quarter. We are launching three new brands this month for which we are already experiencing very strong retail interest. We expect a strong second half from the combination of these new brands and accelerated growth from our existing ingredients portfolio and consumer brands." About Amyris Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries. Forward-Looking Statements
View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-launches-next-virtual-investor-mini-series-301355726.html SOURCE Amyris, Inc. |
||
Company Codes: NASDAQ-NMS:AMRS |